[May 19, 2016]

Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials - Research and Markets

Research and Markets has announced the addition of the "Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview " report to their offering.

Available to Report is Ocular Disorders: Rising Therapeutics, Technologies, and Devices Report. This report begins with outlining Age-related macular degeneration (both wet and dry) and delving into Anti-VEGF therapies in chapter 2. Further providing substantial weight to this report, several companies were interviewed on their approach to targeting wet and dry AMD (News - Alert), their strategies for seeking alternative therapeutic options, and the hardships they have encountered in their research and product execution.

Report highlights include:

- Exclusive interviews from four companies (Oraya Therapeutics, VisionCare Ophthalmic Technologies, Omeros, and Kala Pharmaceuticals) providing details of their products.

- Both invasive and noninvasive procedures are discussed, along with current treatment options and how they relate to rising therapies.

- Demographic survey and analysis of researchers working in ocular disorders including promising therapeutic options, targets of interst, and challenges encountered.

- Over 250 companies featuring clinical trials and pipeline data.

- Over 200 company and institution profiles included

Key Topics Covered:

Executive Summary

CHAPTER 1: Age-Related Macular Degeneration

CHAPTER 2: Therapeutic Efficacy

CHAPTER 3: Oraya Therapeutics

CHAPTER 4: VisionCare Ophthalmic Technologies

CHAPTER 5: Omeros

CHAPTER 6: Kala Pharmaceuticals

CHAPTER 7: Platforms and Products

CHAPTER 8: Survey of Ocular Industry

CHAPTER 9: Clinical Trials and Pipeline Data

Company Profiles - Partial List

- 13therapeutics, Inc.

- 2C Tech Corporation, Inc.

- AbbVie Inc.

- Abdi Ìbrahim Ìlac Sanayi ve Tic A.S. (Abdi Ibrahim)

- AC Immune SA

- ACADIA Pharmaceuticals

- Aciex Therapeutics, Inc.

- Aciont Inc.

- Acorn Biomedical, Inc.

- Actavis hf.

- Acucela Inc.

- Adamed Sp. z o.o.

- Adenovir Pharma AB

- AdeTherapeutics Inc.

- Alcon Laboratories, Inc.

- Alexion Pharmaceuticals, Inc. Translational Medicine Center

- Alimera Sciences, Inc.

- Alkeus Pharmaceuticals, Inc.

- Allegro Ophthalmics LLC

- Allergan, Inc.

- Allergan S.A.U.

- Altacor

- Altheos, Inc.

- Amakem Therapeutics NV

- AmorChem L.P.

- AngioLab, Inc.

- Ångstrom Pharmaceuticals, Inc.

- Apellis Pharmaceuticals, Inc.

- Apitope International NV

- Applied Genetic Technologies Corp. (AGTC)

- ArcticDx, Inc.

- Argos Therapeutics, Inc.

- AriBio

- Ascendis Pharma A/S

For more information visit http://www.researchandmarkets.com/research/2qx6vb/ocular_disorders

View source version on businesswire.com: http://www.businesswire.com/news/home/20160519005676/en/

[ Back To TMCnet.com's Homepage ]